front physiol 6164nelson tm borgogna jl brotman rm ravel j walk st yeo- man cj 2015 vaginal biogenic amines biomarkers of bacterial vaginosis or precursors to vaginal dysbiosis front physiol 6253vorsters a van den bergh j micalessi i biesmans s bogers j hens a et al 2014 optimization of hpv dna detection in urine by improving collection storage and extraction.

j obstet gynaecol res 42121839-1845gok m heideman da van kemenade fj de vries al berkhof j rozendaal l et al 2012 offering self-sampling for human papillomavirus testing to non-attendees of the cervical screen- ing programme characteristics of the responders.

asian pac j cancer prev 15208563-8569marlow la waller j wardle j 2015 barriers to cervical cancer screening among ethnic minority women a qualitative study.

j fam plann reprod health care 414248-254waller j bartoszek m marlow l wardle j 2009 barriers to cervical cancer screening attendance in england a population- based survey.

j am acad dermatol 735759-767joura ea ault ka bosch fx brown d cuzick j ferris d et al 2014 attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease.

eur j gynaecol oncol 353211-218ronco g dillner j elfstrom km tunesi s snijders pj arbyn m et al 2014 efficacy of hpv-based screening for prevention of invasive cervical cancer follow-up of four european randomised controlled trials.

int j cancer 11951095-1101saslow d solomon d lawson hw killackey m kulasingam sl cain j et al 2012 american cancer society american society for colposcopy and cervical pathology and american society for clinical pathology screening guidelines for the pre- vention and early detection of cervical cancer.

j infect 713377-384bosgraaf rp verhoef vm massuger lf siebers ag bulten j de kuyper-de ridder gm et al 2015 comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30130 women not attending cervical screen- ing.

int j cancer 1363646-655ma'som m bhoo-pathy n nasir nh bellinson j subramaniam s ma y et al 2016 attitudes and factors affecting acceptability of self-administered cervicovaginal sampling for human papillo- mavirus hpv genotyping as an alternative to pap testing among multiethnic malaysian women.

j clin virol 542147-151gok m heideman da van kemenade fj berkhof j rozendaal l spruyt jw et al 2010 hpv testing on self collected cervico- vaginal lavage specimens as screening method for women who do not attend cervical screening cohort study.

bmc public health 16832levinson kl abuelo c salmeron j chyung e zou j belin- son se et al 2013 the peru cervical cancer prevention study percaps the technology to make screening accessible.

j cancer res clin oncol 14281751-1763liu j sun h wang x yu q li s yu x et al 2014 increased exosomal microrna-21 and microrna-146a levels in the cer- vicovaginal lavage specimens of patients with cervical cancer.

int j mol sci 151758-773zhang j liu sc luo xh tao gx guan m yuan h et al 2016 exosomal long noncoding rnas are differentially expressed in the cervicovaginal lavage samples of cervical cancer patients.

br j cancer 1124704-713piskareva o harvey h nolan j conlon r alcock l buckley p et al 2015 the development of cisplatin resistance in neuro- blastoma is accompanied by epithelial to mesenchymal transition in vitro.

br j biomed sci 694147-153zhu j wang r cao h zhang h xu s wang a et al 2015 expression of claudin-5 -7 -8 and -9 in cervical carcinoma tis- sues and adjacent non-neoplastic tissues.

